ISIN | LU1048316647 |
---|---|
Valor Number | 24022463 |
Bloomberg Global ID | UEF9 GR |
Fund Name | UBS (Lux) Fund Solutions - Bloomberg US Liquid Corporates UCITS ETF (USD) A-dis |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS AG Basel Phone: +41 61 288 20 20 UBS AG, Zürich Zürich Phone: +41 44 234 11 11 |
Asset Class | Bonds |
EFC Category | Bond Corporate FD USD |
Distribution Policy | Distribution |
Home Country | Luxembourg |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The sub-fund aims to track, before expenses, the price and income performance of the Bloomberg US Liquid Corporates™ Index (Total Return) (this sub-fund's "Index"). Additionally currency hedged share classes aim to reduce the impact of currency fluctuations between their reference currency and the index currency by selling currency forwards at the one-month forward rate in accordance with the hedging methodology of the Index's currency-hedged index variant as referred to in relation to each hedged share class below. |
Peculiarities |
Current Price * | 14.67 USD | 24.04.2025 |
---|---|---|
Previous Price * | 14.58 USD | 23.04.2025 |
52 Week High * | 14.96 USD | 16.09.2024 |
52 Week Low * | 13.70 USD | 25.04.2024 |
NAV * | 14.67 USD | 24.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 509,391,682 | |
Unit/Share Assets *** | 74,323,495 | |
Trading Information SIX |
YTD Performance | +1.72% |
31.12.2024 - 24.04.2025
31.12.2024 24.04.2025 |
---|---|---|
YTD Performance (in CHF) | -7.33% |
31.12.2024 - 24.04.2025
31.12.2024 24.04.2025 |
1 month | -0.32% |
24.03.2025 - 24.04.2025
24.03.2025 24.04.2025 |
3 months | +1.47% |
24.01.2025 - 24.04.2025
24.01.2025 24.04.2025 |
6 months | +0.67% |
24.10.2024 - 24.04.2025
24.10.2024 24.04.2025 |
1 year | +6.70% |
24.04.2024 - 24.04.2025
24.04.2024 24.04.2025 |
2 years | +7.98% |
24.04.2023 - 24.04.2025
24.04.2023 24.04.2025 |
3 years | +6.83% |
25.04.2022 - 24.04.2025
25.04.2022 24.04.2025 |
5 years | -2.23% |
24.04.2020 - 24.04.2025
24.04.2020 24.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Bank of America Corp. | 0.65% | |
---|---|---|
Wells Fargo & Co. | 0.60% | |
Pfizer Investment Enterprises Pte Ltd. | 0.60% | |
Bank of America Corp. | 0.55% | |
Pfizer Investment Enterprises Pte Ltd. | 0.53% | |
Morgan Stanley | 0.50% | |
Pfizer Investment Enterprises Pte Ltd. | 0.49% | |
Wells Fargo & Co. | 0.49% | |
JPMorgan Chase & Co. | 0.48% | |
Bank of America Corp. | 0.47% | |
Last data update | 17.04.2025 |
TER | 0.13% |
---|---|
TER date | 30.06.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.13% |
Ongoing Charges *** | 0.13% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |